nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—CYP3A4—Pimecrolimus—atopic dermatitis	0.0674	0.167	CbGbCtD
Fingolimod—CYP2D6—Loratadine—atopic dermatitis	0.0461	0.114	CbGbCtD
Fingolimod—CYP2D6—Diphenhydramine—atopic dermatitis	0.0461	0.114	CbGbCtD
Fingolimod—CYP3A4—Tacrolimus—atopic dermatitis	0.0401	0.0994	CbGbCtD
Fingolimod—CYP2E1—Dexamethasone—atopic dermatitis	0.0335	0.0831	CbGbCtD
Fingolimod—CYP3A4—Loratadine—atopic dermatitis	0.0293	0.0728	CbGbCtD
Fingolimod—CYP3A4—Methylprednisolone—atopic dermatitis	0.0268	0.0666	CbGbCtD
Fingolimod—CYP3A4—Triamcinolone—atopic dermatitis	0.0203	0.0504	CbGbCtD
Fingolimod—CYP3A4—Betamethasone—atopic dermatitis	0.0174	0.0433	CbGbCtD
Fingolimod—CYP3A4—Prednisolone—atopic dermatitis	0.0172	0.0427	CbGbCtD
Fingolimod—CYP3A4—Hydrocortisone—atopic dermatitis	0.0163	0.0405	CbGbCtD
Fingolimod—CYP3A4—Prednisone—atopic dermatitis	0.0163	0.0403	CbGbCtD
Fingolimod—CYP2D6—Dexamethasone—atopic dermatitis	0.016	0.0396	CbGbCtD
Fingolimod—CYP3A4—Dexamethasone—atopic dermatitis	0.0101	0.0252	CbGbCtD
Fingolimod—S1PR5—skin of body—atopic dermatitis	0.0061	0.241	CbGeAlD
Fingolimod—SPHK1—skin of body—atopic dermatitis	0.00442	0.175	CbGeAlD
Fingolimod—S1PR5—head—atopic dermatitis	0.00398	0.157	CbGeAlD
Fingolimod—CYP4F2—head—atopic dermatitis	0.00373	0.147	CbGeAlD
Fingolimod—S1PR3—head—atopic dermatitis	0.00331	0.131	CbGeAlD
Fingolimod—S1PR1—head—atopic dermatitis	0.00292	0.115	CbGeAlD
Fingolimod—SPHK1—Betamethasone—Desonide—atopic dermatitis	0.00101	0.0934	CbGdCrCtD
Fingolimod—SPHK1—Dexamethasone—Desonide—atopic dermatitis	0.00101	0.0934	CbGdCrCtD
Fingolimod—Palpitations—Diphenhydramine—atopic dermatitis	0.000907	0.00267	CcSEcCtD
Fingolimod—Palpitations—Dimenhydrinate—atopic dermatitis	0.000907	0.00267	CcSEcCtD
Fingolimod—Skin disorder—Fluocinonide—atopic dermatitis	0.000903	0.00266	CcSEcCtD
Fingolimod—Migraine—Tacrolimus—atopic dermatitis	0.000883	0.0026	CcSEcCtD
Fingolimod—Blood triglycerides increased—Prednisone—atopic dermatitis	0.000875	0.00258	CcSEcCtD
Fingolimod—Cough—Pimecrolimus—atopic dermatitis	0.000866	0.00255	CcSEcCtD
Fingolimod—Sinusitis—Fluocinolone Acetonide—atopic dermatitis	0.000853	0.00251	CcSEcCtD
Fingolimod—Cardiac arrest—Tacrolimus—atopic dermatitis	0.000853	0.00251	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Pimecrolimus—atopic dermatitis	0.000839	0.00247	CcSEcCtD
Fingolimod—Liver function test abnormal—Tacrolimus—atopic dermatitis	0.000828	0.00244	CcSEcCtD
Fingolimod—Sinusitis—Mometasone—atopic dermatitis	0.000815	0.0024	CcSEcCtD
Fingolimod—SPHK1—Dexamethasone—Fluocinonide—atopic dermatitis	0.000812	0.0748	CbGdCrCtD
Fingolimod—SPHK1—Betamethasone—Fluocinonide—atopic dermatitis	0.000812	0.0748	CbGdCrCtD
Fingolimod—Pruritus—Desonide—atopic dermatitis	0.000811	0.00239	CcSEcCtD
Fingolimod—Infection—Pimecrolimus—atopic dermatitis	0.000805	0.00237	CcSEcCtD
Fingolimod—Alopecia—Loratadine—atopic dermatitis	0.000803	0.00236	CcSEcCtD
Fingolimod—Connective tissue disorder—Fluocinolone Acetonide—atopic dermatitis	0.000802	0.00236	CcSEcCtD
Fingolimod—Nervous system disorder—Pimecrolimus—atopic dermatitis	0.000794	0.00234	CcSEcCtD
Fingolimod—SPHK1—Dexamethasone—Fluocinolone Acetonide—atopic dermatitis	0.000789	0.0727	CbGdCrCtD
Fingolimod—SPHK1—Betamethasone—Fluocinolone Acetonide—atopic dermatitis	0.000789	0.0727	CbGdCrCtD
Fingolimod—Skin disorder—Pimecrolimus—atopic dermatitis	0.000787	0.00232	CcSEcCtD
Fingolimod—Hypotension—Dimenhydrinate—atopic dermatitis	0.000783	0.00231	CcSEcCtD
Fingolimod—Hypotension—Diphenhydramine—atopic dermatitis	0.000783	0.00231	CcSEcCtD
Fingolimod—Influenza—Tacrolimus—atopic dermatitis	0.000775	0.00228	CcSEcCtD
Fingolimod—Eye disorder—Fluocinolone Acetonide—atopic dermatitis	0.000763	0.00225	CcSEcCtD
Fingolimod—Paraesthesia—Dimenhydrinate—atopic dermatitis	0.000752	0.00222	CcSEcCtD
Fingolimod—Paraesthesia—Diphenhydramine—atopic dermatitis	0.000752	0.00222	CcSEcCtD
Fingolimod—Bronchitis—Tacrolimus—atopic dermatitis	0.000745	0.0022	CcSEcCtD
Fingolimod—Mediastinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.000736	0.00217	CcSEcCtD
Fingolimod—Paraesthesia—Pimecrolimus—atopic dermatitis	0.000727	0.00214	CcSEcCtD
Fingolimod—Fatigue—Diphenhydramine—atopic dermatitis	0.000722	0.00213	CcSEcCtD
Fingolimod—Fatigue—Dimenhydrinate—atopic dermatitis	0.000722	0.00213	CcSEcCtD
Fingolimod—Dyspnoea—Pimecrolimus—atopic dermatitis	0.000722	0.00213	CcSEcCtD
Fingolimod—Alopecia—Fluocinolone Acetonide—atopic dermatitis	0.000721	0.00212	CcSEcCtD
Fingolimod—Headache—Desonide—atopic dermatitis	0.000718	0.00212	CcSEcCtD
Fingolimod—Mental disorder—Fluocinolone Acetonide—atopic dermatitis	0.000715	0.00211	CcSEcCtD
Fingolimod—Mediastinal disorder—Mometasone—atopic dermatitis	0.000702	0.00207	CcSEcCtD
Fingolimod—Weight decreased—Tacrolimus—atopic dermatitis	0.000701	0.00206	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Pimecrolimus—atopic dermatitis	0.000699	0.00206	CcSEcCtD
Fingolimod—Palpitations—Loratadine—atopic dermatitis	0.000699	0.00206	CcSEcCtD
Fingolimod—Pneumonia—Tacrolimus—atopic dermatitis	0.000695	0.00205	CcSEcCtD
Fingolimod—Infestation NOS—Tacrolimus—atopic dermatitis	0.000691	0.00204	CcSEcCtD
Fingolimod—Infestation—Tacrolimus—atopic dermatitis	0.000691	0.00204	CcSEcCtD
Fingolimod—Cough—Loratadine—atopic dermatitis	0.00069	0.00203	CcSEcCtD
Fingolimod—Depression—Tacrolimus—atopic dermatitis	0.000689	0.00203	CcSEcCtD
Fingolimod—Back pain—Fluocinolone Acetonide—atopic dermatitis	0.000687	0.00202	CcSEcCtD
Fingolimod—Hypertension—Loratadine—atopic dermatitis	0.000683	0.00201	CcSEcCtD
Fingolimod—Vision blurred—Fluocinolone Acetonide—atopic dermatitis	0.00067	0.00197	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Loratadine—atopic dermatitis	0.000668	0.00197	CcSEcCtD
Fingolimod—Pruritus—Fluocinonide—atopic dermatitis	0.000657	0.00194	CcSEcCtD
Fingolimod—Back pain—Mometasone—atopic dermatitis	0.000656	0.00193	CcSEcCtD
Fingolimod—Sinusitis—Tacrolimus—atopic dermatitis	0.000648	0.00191	CcSEcCtD
Fingolimod—Nervous system disorder—Loratadine—atopic dermatitis	0.000633	0.00186	CcSEcCtD
Fingolimod—Bradycardia—Tacrolimus—atopic dermatitis	0.000632	0.00186	CcSEcCtD
Fingolimod—Gastroenteritis—Hydrocortisone—atopic dermatitis	0.000631	0.00186	CcSEcCtD
Fingolimod—SPHK1—Betamethasone—Mometasone—atopic dermatitis	0.000629	0.058	CbGdCrCtD
Fingolimod—SPHK1—Dexamethasone—Mometasone—atopic dermatitis	0.000629	0.058	CbGdCrCtD
Fingolimod—Skin disorder—Loratadine—atopic dermatitis	0.000627	0.00185	CcSEcCtD
Fingolimod—Eczema—Hydrocortisone—atopic dermatitis	0.000622	0.00183	CcSEcCtD
Fingolimod—Cough—Fluocinolone Acetonide—atopic dermatitis	0.00062	0.00183	CcSEcCtD
Fingolimod—Dizziness—Fluocinonide—atopic dermatitis	0.000614	0.00181	CcSEcCtD
Fingolimod—Connective tissue disorder—Tacrolimus—atopic dermatitis	0.00061	0.0018	CcSEcCtD
Fingolimod—Hypotension—Loratadine—atopic dermatitis	0.000603	0.00178	CcSEcCtD
Fingolimod—Asthenia—Dimenhydrinate—atopic dermatitis	0.000601	0.00177	CcSEcCtD
Fingolimod—Asthenia—Diphenhydramine—atopic dermatitis	0.000601	0.00177	CcSEcCtD
Fingolimod—Cough—Mometasone—atopic dermatitis	0.000592	0.00174	CcSEcCtD
Fingolimod—Headache—Fluocinonide—atopic dermatitis	0.000582	0.00171	CcSEcCtD
Fingolimod—Eye disorder—Tacrolimus—atopic dermatitis	0.00058	0.00171	CcSEcCtD
Fingolimod—Paraesthesia—Loratadine—atopic dermatitis	0.000579	0.00171	CcSEcCtD
Fingolimod—Infection—Fluocinolone Acetonide—atopic dermatitis	0.000576	0.0017	CcSEcCtD
Fingolimod—Cardiac disorder—Tacrolimus—atopic dermatitis	0.000576	0.0017	CcSEcCtD
Fingolimod—Diarrhoea—Dimenhydrinate—atopic dermatitis	0.000573	0.00169	CcSEcCtD
Fingolimod—Diarrhoea—Diphenhydramine—atopic dermatitis	0.000573	0.00169	CcSEcCtD
Fingolimod—Pruritus—Pimecrolimus—atopic dermatitis	0.000573	0.00169	CcSEcCtD
Fingolimod—Nervous system disorder—Fluocinolone Acetonide—atopic dermatitis	0.000569	0.00167	CcSEcCtD
Fingolimod—Angiopathy—Tacrolimus—atopic dermatitis	0.000563	0.00166	CcSEcCtD
Fingolimod—Mediastinal disorder—Tacrolimus—atopic dermatitis	0.000559	0.00165	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Loratadine—atopic dermatitis	0.000557	0.00164	CcSEcCtD
Fingolimod—Fatigue—Loratadine—atopic dermatitis	0.000556	0.00164	CcSEcCtD
Fingolimod—Diarrhoea—Pimecrolimus—atopic dermatitis	0.000554	0.00163	CcSEcCtD
Fingolimod—Dizziness—Diphenhydramine—atopic dermatitis	0.000554	0.00163	CcSEcCtD
Fingolimod—Dizziness—Dimenhydrinate—atopic dermatitis	0.000554	0.00163	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—CCL17—atopic dermatitis	0.000552	0.0025	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—CXCL10—atopic dermatitis	0.00055	0.00249	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—CXCL10—atopic dermatitis	0.00055	0.00249	CbGpPWpGaD
Fingolimod—Infection—Mometasone—atopic dermatitis	0.00055	0.00162	CcSEcCtD
Fingolimod—Alopecia—Tacrolimus—atopic dermatitis	0.000548	0.00161	CcSEcCtD
Fingolimod—Cardiac arrest—Prednisolone—atopic dermatitis	0.000545	0.0016	CcSEcCtD
Fingolimod—Mental disorder—Tacrolimus—atopic dermatitis	0.000543	0.0016	CcSEcCtD
Fingolimod—SPHK1—Metabolism of proteins—CMA1—atopic dermatitis	0.00054	0.00244	CbGpPWpGaD
Fingolimod—Cardiac arrest—Hydrocortisone—atopic dermatitis	0.000532	0.00157	CcSEcCtD
Fingolimod—Eye pain—Dexamethasone—atopic dermatitis	0.000529	0.00156	CcSEcCtD
Fingolimod—Eye pain—Betamethasone—atopic dermatitis	0.000529	0.00156	CcSEcCtD
Fingolimod—Headache—Dimenhydrinate—atopic dermatitis	0.000525	0.00155	CcSEcCtD
Fingolimod—Headache—Diphenhydramine—atopic dermatitis	0.000525	0.00155	CcSEcCtD
Fingolimod—Back pain—Tacrolimus—atopic dermatitis	0.000522	0.00154	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—CCL11—atopic dermatitis	0.000509	0.0023	CbGpPWpGaD
Fingolimod—Vision blurred—Tacrolimus—atopic dermatitis	0.000509	0.0015	CcSEcCtD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000509	0.0023	CbGpPWpGaD
Fingolimod—Headache—Pimecrolimus—atopic dermatitis	0.000508	0.00149	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—FCER2—atopic dermatitis	0.000502	0.00227	CbGpPWpGaD
Fingolimod—Cardiac arrest—Triamcinolone—atopic dermatitis	0.000501	0.00147	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.000501	0.00147	CcSEcCtD
Fingolimod—Cardiac arrest—Methylprednisolone—atopic dermatitis	0.0005	0.00147	CcSEcCtD
Fingolimod—S1PR1—GPCR ligand binding—CXCL10—atopic dermatitis	0.0005	0.00226	CbGpPWpGaD
Fingolimod—SPHK1—PDGFR-beta signaling pathway—MAPK8—atopic dermatitis	0.000499	0.00226	CbGpPWpGaD
Fingolimod—Paraesthesia—Mometasone—atopic dermatitis	0.000497	0.00146	CcSEcCtD
Fingolimod—CYP4F12—Metabolism—GLB1—atopic dermatitis	0.000495	0.00224	CbGpPWpGaD
Fingolimod—Dyspnoea—Mometasone—atopic dermatitis	0.000494	0.00145	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Hydrocortisone—atopic dermatitis	0.000493	0.00145	CcSEcCtD
Fingolimod—S1PR4—GPCR ligand binding—CCL5—atopic dermatitis	0.000492	0.00222	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—CCL11—atopic dermatitis	0.00049	0.00222	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—CCL11—atopic dermatitis	0.00049	0.00222	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—FCER2—atopic dermatitis	0.000484	0.00219	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—FCER2—atopic dermatitis	0.000484	0.00219	CbGpPWpGaD
Fingolimod—Leukopenia—Tacrolimus—atopic dermatitis	0.000483	0.00142	CcSEcCtD
Fingolimod—Fatigue—Mometasone—atopic dermatitis	0.000477	0.00141	CcSEcCtD
Fingolimod—Palpitations—Tacrolimus—atopic dermatitis	0.000477	0.00141	CcSEcCtD
Fingolimod—CYP4F12—Metabolism—ADSL—atopic dermatitis	0.000475	0.00215	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—CCL5—atopic dermatitis	0.000474	0.00214	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—CCL5—atopic dermatitis	0.000474	0.00214	CbGpPWpGaD
Fingolimod—Cough—Tacrolimus—atopic dermatitis	0.000471	0.00139	CcSEcCtD
Fingolimod—Migraine—Dexamethasone—atopic dermatitis	0.00047	0.00139	CcSEcCtD
Fingolimod—Migraine—Betamethasone—atopic dermatitis	0.00047	0.00139	CcSEcCtD
Fingolimod—CYP2E1—head—atopic dermatitis	0.000468	0.0185	CbGeAlD
Fingolimod—S1PR4—Signaling Pathways—CCL22—atopic dermatitis	0.000467	0.00211	CbGpPWpGaD
Fingolimod—Hypertension—Tacrolimus—atopic dermatitis	0.000466	0.00137	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Methylprednisolone—atopic dermatitis	0.000464	0.00137	CcSEcCtD
Fingolimod—Asthenia—Loratadine—atopic dermatitis	0.000463	0.00136	CcSEcCtD
Fingolimod—S1PR4—GPCR downstream signaling—CCR3—atopic dermatitis	0.000457	0.00207	CbGpPWpGaD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Tacrolimus—atopic dermatitis	0.000457	0.00134	CcSEcCtD
Fingolimod—Influenza—Triamcinolone—atopic dermatitis	0.000455	0.00134	CcSEcCtD
Fingolimod—Cardiac arrest—Dexamethasone—atopic dermatitis	0.000454	0.00134	CcSEcCtD
Fingolimod—Cardiac arrest—Betamethasone—atopic dermatitis	0.000454	0.00134	CcSEcCtD
Fingolimod—S1PR3—Signaling Pathways—CCL22—atopic dermatitis	0.000449	0.00203	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CCL22—atopic dermatitis	0.000449	0.00203	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—CCL11—atopic dermatitis	0.000445	0.00201	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—CCR5—atopic dermatitis	0.000443	0.002	CbGpPWpGaD
Fingolimod—S1PR4—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000443	0.002	CbGpPWpGaD
Fingolimod—Diarrhoea—Loratadine—atopic dermatitis	0.000441	0.0013	CcSEcCtD
Fingolimod—S1PR5—GPCR downstream signaling—CCR3—atopic dermatitis	0.00044	0.00199	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—CCR3—atopic dermatitis	0.00044	0.00199	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—FCER2—atopic dermatitis	0.000439	0.00198	CbGpPWpGaD
Fingolimod—Infection—Tacrolimus—atopic dermatitis	0.000438	0.00129	CcSEcCtD
Fingolimod—Bronchitis—Triamcinolone—atopic dermatitis	0.000438	0.00129	CcSEcCtD
Fingolimod—Weight decreased—Hydrocortisone—atopic dermatitis	0.000437	0.00129	CcSEcCtD
Fingolimod—Nervous system disorder—Tacrolimus—atopic dermatitis	0.000432	0.00127	CcSEcCtD
Fingolimod—Infestation NOS—Hydrocortisone—atopic dermatitis	0.000431	0.00127	CcSEcCtD
Fingolimod—Infestation—Hydrocortisone—atopic dermatitis	0.000431	0.00127	CcSEcCtD
Fingolimod—S1PR1—GPCR ligand binding—CCL5—atopic dermatitis	0.00043	0.00194	CbGpPWpGaD
Fingolimod—Skin disorder—Tacrolimus—atopic dermatitis	0.000428	0.00126	CcSEcCtD
Fingolimod—CYP4F2—Metabolism—GLB1—atopic dermatitis	0.000428	0.00193	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—CCR5—atopic dermatitis	0.000427	0.00193	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—CCR5—atopic dermatitis	0.000427	0.00193	CbGpPWpGaD
Fingolimod—Dizziness—Loratadine—atopic dermatitis	0.000427	0.00126	CcSEcCtD
Fingolimod—S1PR3—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000426	0.00193	CbGpPWpGaD
Fingolimod—S1PR5—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000426	0.00193	CbGpPWpGaD
Fingolimod—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000419	0.00189	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CCL27—atopic dermatitis	0.000416	0.00188	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—CCR3—atopic dermatitis	0.000415	0.00188	CbGpPWpGaD
Fingolimod—Hypotension—Tacrolimus—atopic dermatitis	0.000412	0.00121	CcSEcCtD
Fingolimod—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.00041	0.00121	CcSEcCtD
Fingolimod—CYP4F2—Metabolism—ADSL—atopic dermatitis	0.00041	0.00185	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CCL22—atopic dermatitis	0.000408	0.00185	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—TAC1—atopic dermatitis	0.000408	0.00184	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—NPS—atopic dermatitis	0.000408	0.00184	CbGpPWpGaD
Fingolimod—Infestation NOS—Methylprednisolone—atopic dermatitis	0.000405	0.00119	CcSEcCtD
Fingolimod—Infestation—Methylprednisolone—atopic dermatitis	0.000405	0.00119	CcSEcCtD
Fingolimod—Headache—Loratadine—atopic dermatitis	0.000404	0.00119	CcSEcCtD
Fingolimod—Bradycardia—Prednisolone—atopic dermatitis	0.000403	0.00119	CcSEcCtD
Fingolimod—S1PR3—Signaling Pathways—CCL27—atopic dermatitis	0.000401	0.00181	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CCL27—atopic dermatitis	0.000401	0.00181	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—CCR3—atopic dermatitis	0.0004	0.00181	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—CCR3—atopic dermatitis	0.0004	0.00181	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—CCR3—atopic dermatitis	0.0004	0.00181	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—CXCR3—atopic dermatitis	0.0004	0.00181	CbGpPWpGaD
Fingolimod—SPHK1—Dexamethasone—Hydrocortisone—atopic dermatitis	0.000398	0.0367	CbGdCrCtD
Fingolimod—SPHK1—Betamethasone—Hydrocortisone—atopic dermatitis	0.000398	0.0367	CbGdCrCtD
Fingolimod—Asthenia—Mometasone—atopic dermatitis	0.000397	0.00117	CcSEcCtD
Fingolimod—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000397	0.00117	CcSEcCtD
Fingolimod—Cardiac arrest—Prednisone—atopic dermatitis	0.000396	0.00117	CcSEcCtD
Fingolimod—Paraesthesia—Tacrolimus—atopic dermatitis	0.000396	0.00117	CcSEcCtD
Fingolimod—Bradycardia—Hydrocortisone—atopic dermatitis	0.000394	0.00116	CcSEcCtD
Fingolimod—Dyspnoea—Tacrolimus—atopic dermatitis	0.000393	0.00116	CcSEcCtD
Fingolimod—S1PR3—GPCR downstream signaling—NPS—atopic dermatitis	0.000392	0.00177	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—TAC1—atopic dermatitis	0.000392	0.00177	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—NPS—atopic dermatitis	0.000392	0.00177	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—TAC1—atopic dermatitis	0.000392	0.00177	CbGpPWpGaD
Fingolimod—Pruritus—Mometasone—atopic dermatitis	0.000392	0.00115	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—FCER2—atopic dermatitis	0.000389	0.00176	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—CCR5—atopic dermatitis	0.000388	0.00175	CbGpPWpGaD
Fingolimod—S1PR1—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000387	0.00175	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000385	0.00174	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000385	0.00174	CbGpPWpGaD
Fingolimod—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000383	0.00113	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.00038	0.00112	CcSEcCtD
Fingolimod—Connective tissue disorder—Hydrocortisone—atopic dermatitis	0.00038	0.00112	CcSEcCtD
Fingolimod—Fatigue—Tacrolimus—atopic dermatitis	0.00038	0.00112	CcSEcCtD
Fingolimod—S1PR4—GPCR downstream signaling—IL5—atopic dermatitis	0.000379	0.00171	CbGpPWpGaD
Fingolimod—Diarrhoea—Mometasone—atopic dermatitis	0.000379	0.00112	CcSEcCtD
Fingolimod—SPHK1—Betamethasone—Methylprednisolone—atopic dermatitis	0.000376	0.0346	CbGdCrCtD
Fingolimod—SPHK1—Dexamethasone—Methylprednisolone—atopic dermatitis	0.000376	0.0346	CbGdCrCtD
Fingolimod—Weight decreased—Betamethasone—atopic dermatitis	0.000374	0.0011	CcSEcCtD
Fingolimod—Weight decreased—Dexamethasone—atopic dermatitis	0.000374	0.0011	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—CCL17—atopic dermatitis	0.000373	0.00169	CbGpPWpGaD
Fingolimod—Bradycardia—Triamcinolone—atopic dermatitis	0.000371	0.00109	CcSEcCtD
Fingolimod—CYP2D6—head—atopic dermatitis	0.00037	0.0146	CbGeAlD
Fingolimod—Bradycardia—Methylprednisolone—atopic dermatitis	0.00037	0.00109	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—NPS—atopic dermatitis	0.00037	0.00167	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—TAC1—atopic dermatitis	0.00037	0.00167	CbGpPWpGaD
Fingolimod—SPHK1—Betamethasone—Dexamethasone—atopic dermatitis	0.00037	0.0341	CbGdCrCtD
Fingolimod—SPHK1—Dexamethasone—Betamethasone—atopic dermatitis	0.00037	0.0341	CbGdCrCtD
Fingolimod—SPHK1—Metabolism—GLB1—atopic dermatitis	0.000367	0.00166	CbGpPWpGaD
Fingolimod—Alanine aminotransferase increased—Prednisone—atopic dermatitis	0.000367	0.00108	CcSEcCtD
Fingolimod—S1PR3—GPCR downstream signaling—IL5—atopic dermatitis	0.000365	0.00165	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—IL5—atopic dermatitis	0.000365	0.00165	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CCL27—atopic dermatitis	0.000364	0.00164	CbGpPWpGaD
Fingolimod—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000363	0.00107	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—CCR3—atopic dermatitis	0.000363	0.00164	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—CXCR3—atopic dermatitis	0.000363	0.00164	CbGpPWpGaD
Fingolimod—Eye disorder—Hydrocortisone—atopic dermatitis	0.000362	0.00107	CcSEcCtD
Fingolimod—SPHK1—Dexamethasone—Triamcinolone—atopic dermatitis	0.000361	0.0333	CbGdCrCtD
Fingolimod—SPHK1—Betamethasone—Triamcinolone—atopic dermatitis	0.000361	0.0333	CbGdCrCtD
Fingolimod—SPHK1—Signaling Pathways—CCL22—atopic dermatitis	0.000361	0.00163	CbGpPWpGaD
Fingolimod—SPHK1—VEGFA-VEGFR2 Pathway—IL6—atopic dermatitis	0.000361	0.00163	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CCL17—atopic dermatitis	0.000359	0.00162	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CCL17—atopic dermatitis	0.000359	0.00162	CbGpPWpGaD
Fingolimod—Connective tissue disorder—Methylprednisolone—atopic dermatitis	0.000357	0.00105	CcSEcCtD
Fingolimod—S1PR3—Signaling by GPCR—TAC1—atopic dermatitis	0.000356	0.00161	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—NPS—atopic dermatitis	0.000356	0.00161	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—TAC1—atopic dermatitis	0.000356	0.00161	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—NPS—atopic dermatitis	0.000356	0.00161	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—NPS—atopic dermatitis	0.000356	0.00161	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—TAC1—atopic dermatitis	0.000356	0.00161	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—ADSL—atopic dermatitis	0.000352	0.00159	CbGpPWpGaD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000352	0.00159	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—CXCR3—atopic dermatitis	0.000349	0.00158	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—CXCR3—atopic dermatitis	0.000349	0.00158	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000349	0.00158	CbGpPWpGaD
Fingolimod—Headache—Mometasone—atopic dermatitis	0.000347	0.00102	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—IL5—atopic dermatitis	0.000344	0.00156	CbGpPWpGaD
Fingolimod—SPHK1—Betamethasone—Prednisone—atopic dermatitis	0.000343	0.0316	CbGdCrCtD
Fingolimod—SPHK1—Dexamethasone—Prednisone—atopic dermatitis	0.000343	0.0316	CbGdCrCtD
Fingolimod—SPHK1—Signaling by VEGF—IL6—atopic dermatitis	0.000341	0.00154	CbGpPWpGaD
Fingolimod—Eye disorder—Methylprednisolone—atopic dermatitis	0.00034	0.001	CcSEcCtD
Fingolimod—Mental disorder—Hydrocortisone—atopic dermatitis	0.000339	0.000998	CcSEcCtD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000339	0.00153	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000339	0.00153	CbGpPWpGaD
Fingolimod—Cardiac disorder—Methylprednisolone—atopic dermatitis	0.000337	0.000994	CcSEcCtD
Fingolimod—Bradycardia—Betamethasone—atopic dermatitis	0.000337	0.000991	CcSEcCtD
Fingolimod—Bradycardia—Dexamethasone—atopic dermatitis	0.000337	0.000991	CcSEcCtD
Fingolimod—SPHK1—Dexamethasone—Prednisolone—atopic dermatitis	0.000335	0.0309	CbGdCrCtD
Fingolimod—SPHK1—Betamethasone—Prednisolone—atopic dermatitis	0.000335	0.0309	CbGdCrCtD
Fingolimod—S1PR4—Signaling Pathways—KIF3A—atopic dermatitis	0.000333	0.0015	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—IL5—atopic dermatitis	0.000331	0.0015	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—IL5—atopic dermatitis	0.000331	0.0015	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—IL5—atopic dermatitis	0.000331	0.0015	CbGpPWpGaD
Fingolimod—Angiopathy—Methylprednisolone—atopic dermatitis	0.00033	0.000971	CcSEcCtD
Fingolimod—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.000328	0.000965	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—CCL17—atopic dermatitis	0.000326	0.00148	CbGpPWpGaD
Fingolimod—Weight decreased—Prednisone—atopic dermatitis	0.000325	0.000958	CcSEcCtD
Fingolimod—Vision blurred—Prednisolone—atopic dermatitis	0.000325	0.000957	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—NPS—atopic dermatitis	0.000324	0.00146	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—TAC1—atopic dermatitis	0.000324	0.00146	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000323	0.00146	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CCL27—atopic dermatitis	0.000322	0.00146	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—KIF3A—atopic dermatitis	0.00032	0.00145	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—KIF3A—atopic dermatitis	0.00032	0.00145	CbGpPWpGaD
Fingolimod—Depression—Prednisone—atopic dermatitis	0.00032	0.000942	CcSEcCtD
Fingolimod—Mental disorder—Methylprednisolone—atopic dermatitis	0.000319	0.000938	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—CXCR3—atopic dermatitis	0.000317	0.00143	CbGpPWpGaD
Fingolimod—Asthenia—Tacrolimus—atopic dermatitis	0.000316	0.000931	CcSEcCtD
Fingolimod—Pruritus—Tacrolimus—atopic dermatitis	0.000312	0.000918	CcSEcCtD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	0.000312	0.00141	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000311	0.00141	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000311	0.00141	CbGpPWpGaD
Fingolimod—Eye disorder—Dexamethasone—atopic dermatitis	0.000309	0.00091	CcSEcCtD
Fingolimod—Eye disorder—Betamethasone—atopic dermatitis	0.000309	0.00091	CcSEcCtD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000308	0.00139	CbGpPWpGaD
Fingolimod—Back pain—Triamcinolone—atopic dermatitis	0.000307	0.000904	CcSEcCtD
Fingolimod—Diarrhoea—Tacrolimus—atopic dermatitis	0.000302	0.000888	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—CMA1—atopic dermatitis	0.000301	0.00136	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CCL11—atopic dermatitis	0.000301	0.00136	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—IL5—atopic dermatitis	0.000301	0.00136	CbGpPWpGaD
Fingolimod—Angiopathy—Betamethasone—atopic dermatitis	0.0003	0.000883	CcSEcCtD
Fingolimod—Angiopathy—Dexamethasone—atopic dermatitis	0.0003	0.000883	CcSEcCtD
Fingolimod—Hypertension—Prednisolone—atopic dermatitis	0.000298	0.000877	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—CXCL10—atopic dermatitis	0.000293	0.00133	CbGpPWpGaD
Fingolimod—Bradycardia—Prednisone—atopic dermatitis	0.000293	0.000863	CcSEcCtD
Fingolimod—Alopecia—Betamethasone—atopic dermatitis	0.000292	0.00086	CcSEcCtD
Fingolimod—Alopecia—Dexamethasone—atopic dermatitis	0.000292	0.00086	CcSEcCtD
Fingolimod—Dizziness—Tacrolimus—atopic dermatitis	0.000291	0.000858	CcSEcCtD
Fingolimod—Hypertension—Hydrocortisone—atopic dermatitis	0.000291	0.000857	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—KIF3A—atopic dermatitis	0.000291	0.00131	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CMA1—atopic dermatitis	0.00029	0.00131	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CMA1—atopic dermatitis	0.00029	0.00131	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CCL11—atopic dermatitis	0.00029	0.00131	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CCL11—atopic dermatitis	0.00029	0.00131	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CCL17—atopic dermatitis	0.000289	0.00131	CbGpPWpGaD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000285	0.000839	CcSEcCtD
Fingolimod—Connective tissue disorder—Prednisone—atopic dermatitis	0.000283	0.000833	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—STAT6—atopic dermatitis	0.000283	0.00128	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—CXCL10—atopic dermatitis	0.000282	0.00128	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—CXCL10—atopic dermatitis	0.000282	0.00128	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000282	0.00128	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—CCL5—atopic dermatitis	0.000278	0.00126	CbGpPWpGaD
Fingolimod—Cough—Triamcinolone—atopic dermatitis	0.000277	0.000815	CcSEcCtD
Fingolimod—Headache—Tacrolimus—atopic dermatitis	0.000276	0.000813	CcSEcCtD
Fingolimod—Hypertension—Triamcinolone—atopic dermatitis	0.000274	0.000806	CcSEcCtD
Fingolimod—Hypertension—Methylprednisolone—atopic dermatitis	0.000273	0.000805	CcSEcCtD
Fingolimod—Infection—Hydrocortisone—atopic dermatitis	0.000273	0.000804	CcSEcCtD
Fingolimod—S1PR5—Signaling Pathways—STAT6—atopic dermatitis	0.000272	0.00123	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—STAT6—atopic dermatitis	0.000272	0.00123	CbGpPWpGaD
Fingolimod—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.00027	0.000794	CcSEcCtD
Fingolimod—Eye disorder—Prednisone—atopic dermatitis	0.000269	0.000792	CcSEcCtD
Fingolimod—S1PR4—GPCR ligand binding—CXCL8—atopic dermatitis	0.000268	0.00121	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—CCL5—atopic dermatitis	0.000268	0.00121	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—CCL5—atopic dermatitis	0.000268	0.00121	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	0.000268	0.00121	CbGpPWpGaD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000268	0.000788	CcSEcCtD
Fingolimod—Skin disorder—Hydrocortisone—atopic dermatitis	0.000267	0.000786	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—CMA1—atopic dermatitis	0.000263	0.00119	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CCL11—atopic dermatitis	0.000263	0.00119	CbGpPWpGaD
Fingolimod—Angiopathy—Prednisone—atopic dermatitis	0.000261	0.000769	CcSEcCtD
Fingolimod—S1PR3—GPCR ligand binding—CXCL8—atopic dermatitis	0.000258	0.00117	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—CXCL8—atopic dermatitis	0.000258	0.00117	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—KIF3A—atopic dermatitis	0.000257	0.00116	CbGpPWpGaD
Fingolimod—Infection—Triamcinolone—atopic dermatitis	0.000257	0.000757	CcSEcCtD
Fingolimod—Hypotension—Hydrocortisone—atopic dermatitis	0.000257	0.000757	CcSEcCtD
Fingolimod—Infection—Methylprednisolone—atopic dermatitis	0.000257	0.000756	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—CXCL10—atopic dermatitis	0.000256	0.00116	CbGpPWpGaD
Fingolimod—Alopecia—Prednisone—atopic dermatitis	0.000254	0.000749	CcSEcCtD
Fingolimod—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000253	0.000746	CcSEcCtD
Fingolimod—Paraesthesia—Prednisolone—atopic dermatitis	0.000253	0.000744	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—CCL5—atopic dermatitis	0.000253	0.00114	CbGpPWpGaD
Fingolimod—Mental disorder—Prednisone—atopic dermatitis	0.000252	0.000743	CcSEcCtD
Fingolimod—Skin disorder—Methylprednisolone—atopic dermatitis	0.000251	0.000739	CcSEcCtD
Fingolimod—S1PR4—GPCR downstream signaling—CCR5—atopic dermatitis	0.000251	0.00113	CbGpPWpGaD
Fingolimod—Hypertension—Dexamethasone—atopic dermatitis	0.000248	0.000732	CcSEcCtD
Fingolimod—Hypertension—Betamethasone—atopic dermatitis	0.000248	0.000732	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—STAT6—atopic dermatitis	0.000247	0.00112	CbGpPWpGaD
Fingolimod—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000247	0.000727	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—CCR3—atopic dermatitis	0.000245	0.00111	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—CCL5—atopic dermatitis	0.000243	0.0011	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—CCL5—atopic dermatitis	0.000243	0.0011	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—CCL5—atopic dermatitis	0.000243	0.0011	CbGpPWpGaD
Fingolimod—Hypotension—Methylprednisolone—atopic dermatitis	0.000241	0.000711	CcSEcCtD
Fingolimod—S1PR5—GPCR downstream signaling—CCR5—atopic dermatitis	0.000241	0.00109	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—CCR5—atopic dermatitis	0.000241	0.00109	CbGpPWpGaD
Fingolimod—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000237	0.000699	CcSEcCtD
Fingolimod—Fatigue—Hydrocortisone—atopic dermatitis	0.000237	0.000698	CcSEcCtD
Fingolimod—Vision blurred—Prednisone—atopic dermatitis	0.000236	0.000696	CcSEcCtD
Fingolimod—S1PR5—Signaling Pathways—CCR3—atopic dermatitis	0.000236	0.00107	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CCR3—atopic dermatitis	0.000236	0.00107	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—CXCL8—atopic dermatitis	0.000234	0.00106	CbGpPWpGaD
Fingolimod—Infection—Dexamethasone—atopic dermatitis	0.000233	0.000687	CcSEcCtD
Fingolimod—Infection—Betamethasone—atopic dermatitis	0.000233	0.000687	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—CMA1—atopic dermatitis	0.000233	0.00105	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CCL11—atopic dermatitis	0.000233	0.00105	CbGpPWpGaD
Fingolimod—Paraesthesia—Triamcinolone—atopic dermatitis	0.000232	0.000685	CcSEcCtD
Fingolimod—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000232	0.000683	CcSEcCtD
Fingolimod—Dyspnoea—Triamcinolone—atopic dermatitis	0.000231	0.00068	CcSEcCtD
Fingolimod—Nervous system disorder—Dexamethasone—atopic dermatitis	0.00023	0.000678	CcSEcCtD
Fingolimod—Nervous system disorder—Betamethasone—atopic dermatitis	0.00023	0.000678	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—CCR5—atopic dermatitis	0.000228	0.00103	CbGpPWpGaD
Fingolimod—Fatigue—Triamcinolone—atopic dermatitis	0.000223	0.000657	CcSEcCtD
Fingolimod—Fatigue—Methylprednisolone—atopic dermatitis	0.000223	0.000656	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—CCL5—atopic dermatitis	0.000221	0.000998	CbGpPWpGaD
Fingolimod—Hypotension—Betamethasone—atopic dermatitis	0.000219	0.000646	CcSEcCtD
Fingolimod—Hypotension—Dexamethasone—atopic dermatitis	0.000219	0.000646	CcSEcCtD
Fingolimod—S1PR5—Signaling by GPCR—CCR5—atopic dermatitis	0.000219	0.00099	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—CCR5—atopic dermatitis	0.000219	0.00099	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—CCR5—atopic dermatitis	0.000219	0.00099	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—STAT6—atopic dermatitis	0.000219	0.000989	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—NPS—atopic dermatitis	0.000219	0.000988	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TAC1—atopic dermatitis	0.000219	0.000988	CbGpPWpGaD
Fingolimod—Hypertension—Prednisone—atopic dermatitis	0.000216	0.000637	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—CCR3—atopic dermatitis	0.000214	0.000969	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CXCR3—atopic dermatitis	0.000214	0.000969	CbGpPWpGaD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000212	0.000624	CcSEcCtD
Fingolimod—Paraesthesia—Betamethasone—atopic dermatitis	0.000211	0.000621	CcSEcCtD
Fingolimod—Paraesthesia—Dexamethasone—atopic dermatitis	0.000211	0.000621	CcSEcCtD
Fingolimod—S1PR3—Signaling Pathways—TAC1—atopic dermatitis	0.00021	0.000951	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—NPS—atopic dermatitis	0.00021	0.000951	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TAC1—atopic dermatitis	0.00021	0.000951	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NPS—atopic dermatitis	0.00021	0.000951	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CXCR3—atopic dermatitis	0.000206	0.000933	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CXCR3—atopic dermatitis	0.000206	0.000933	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IL5—atopic dermatitis	0.000203	0.000919	CbGpPWpGaD
Fingolimod—Infection—Prednisone—atopic dermatitis	0.000203	0.000598	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000203	0.000597	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000203	0.000597	CcSEcCtD
Fingolimod—Fatigue—Betamethasone—atopic dermatitis	0.000203	0.000596	CcSEcCtD
Fingolimod—Fatigue—Dexamethasone—atopic dermatitis	0.000203	0.000596	CcSEcCtD
Fingolimod—Nervous system disorder—Prednisone—atopic dermatitis	0.000201	0.000591	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—CCR5—atopic dermatitis	0.000199	0.000899	CbGpPWpGaD
Fingolimod—Skin disorder—Prednisone—atopic dermatitis	0.000199	0.000585	CcSEcCtD
Fingolimod—Asthenia—Hydrocortisone—atopic dermatitis	0.000197	0.000581	CcSEcCtD
Fingolimod—S1PR5—Signaling Pathways—IL5—atopic dermatitis	0.000196	0.000885	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IL5—atopic dermatitis	0.000196	0.000885	CbGpPWpGaD
Fingolimod—Pruritus—Hydrocortisone—atopic dermatitis	0.000195	0.000573	CcSEcCtD
Fingolimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000194	0.000878	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TAC1—atopic dermatitis	0.000191	0.000864	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NPS—atopic dermatitis	0.000191	0.000864	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CCR3—atopic dermatitis	0.00019	0.000858	CbGpPWpGaD
Fingolimod—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000188	0.000554	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—CXCR3—atopic dermatitis	0.000187	0.000847	CbGpPWpGaD
Fingolimod—Dizziness—Prednisolone—atopic dermatitis	0.000186	0.000548	CcSEcCtD
Fingolimod—Asthenia—Triamcinolone—atopic dermatitis	0.000186	0.000547	CcSEcCtD
Fingolimod—Asthenia—Methylprednisolone—atopic dermatitis	0.000185	0.000546	CcSEcCtD
Fingolimod—Paraesthesia—Prednisone—atopic dermatitis	0.000184	0.000541	CcSEcCtD
Fingolimod—Pruritus—Triamcinolone—atopic dermatitis	0.000183	0.000539	CcSEcCtD
Fingolimod—Pruritus—Methylprednisolone—atopic dermatitis	0.000183	0.000538	CcSEcCtD
Fingolimod—Dizziness—Hydrocortisone—atopic dermatitis	0.000182	0.000535	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—IL5—atopic dermatitis	0.000178	0.000803	CbGpPWpGaD
Fingolimod—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000177	0.00052	CcSEcCtD
Fingolimod—Fatigue—Prednisone—atopic dermatitis	0.000176	0.000519	CcSEcCtD
Fingolimod—Headache—Prednisolone—atopic dermatitis	0.000176	0.000519	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—CXCL10—atopic dermatitis	0.000173	0.000783	CbGpPWpGaD
Fingolimod—Headache—Hydrocortisone—atopic dermatitis	0.000172	0.000507	CcSEcCtD
Fingolimod—Dizziness—Triamcinolone—atopic dermatitis	0.000171	0.000504	CcSEcCtD
Fingolimod—Dizziness—Methylprednisolone—atopic dermatitis	0.000171	0.000503	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—NPS—atopic dermatitis	0.000169	0.000765	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TAC1—atopic dermatitis	0.000169	0.000765	CbGpPWpGaD
Fingolimod—Asthenia—Dexamethasone—atopic dermatitis	0.000169	0.000496	CcSEcCtD
Fingolimod—Asthenia—Betamethasone—atopic dermatitis	0.000169	0.000496	CcSEcCtD
Fingolimod—S1PR3—Signaling Pathways—CXCL10—atopic dermatitis	0.000167	0.000754	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CXCL10—atopic dermatitis	0.000167	0.000754	CbGpPWpGaD
Fingolimod—Pruritus—Betamethasone—atopic dermatitis	0.000166	0.000489	CcSEcCtD
Fingolimod—Pruritus—Dexamethasone—atopic dermatitis	0.000166	0.000489	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—CXCR3—atopic dermatitis	0.000166	0.00075	CbGpPWpGaD
Fingolimod—Headache—Triamcinolone—atopic dermatitis	0.000162	0.000478	CcSEcCtD
Fingolimod—Headache—Methylprednisolone—atopic dermatitis	0.000162	0.000477	CcSEcCtD
Fingolimod—CYP4F12—Metabolism—PPARA—atopic dermatitis	0.000161	0.000727	CbGpPWpGaD
Fingolimod—Diarrhoea—Betamethasone—atopic dermatitis	0.000161	0.000473	CcSEcCtD
Fingolimod—Diarrhoea—Dexamethasone—atopic dermatitis	0.000161	0.000473	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—IL5—atopic dermatitis	0.000157	0.000711	CbGpPWpGaD
Fingolimod—Dizziness—Dexamethasone—atopic dermatitis	0.000155	0.000457	CcSEcCtD
Fingolimod—Dizziness—Betamethasone—atopic dermatitis	0.000155	0.000457	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—CXCL10—atopic dermatitis	0.000151	0.000685	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000151	0.000685	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CCL5—atopic dermatitis	0.000149	0.000674	CbGpPWpGaD
Fingolimod—Headache—Dexamethasone—atopic dermatitis	0.000147	0.000433	CcSEcCtD
Fingolimod—Headache—Betamethasone—atopic dermatitis	0.000147	0.000433	CcSEcCtD
Fingolimod—Asthenia—Prednisone—atopic dermatitis	0.000147	0.000432	CcSEcCtD
Fingolimod—SPHK1—Metabolism of proteins—CXCL8—atopic dermatitis	0.000146	0.000659	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000146	0.000659	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000146	0.000659	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—IL2—atopic dermatitis	0.000145	0.000654	CbGpPWpGaD
Fingolimod—Pruritus—Prednisone—atopic dermatitis	0.000145	0.000426	CcSEcCtD
Fingolimod—S1PR3—Signaling Pathways—CCL5—atopic dermatitis	0.000144	0.000649	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CCL5—atopic dermatitis	0.000144	0.000649	CbGpPWpGaD
Fingolimod—Diarrhoea—Prednisone—atopic dermatitis	0.00014	0.000412	CcSEcCtD
Fingolimod—S1PR5—GPCR downstream signaling—IL2—atopic dermatitis	0.000139	0.00063	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—IL2—atopic dermatitis	0.000139	0.00063	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PPARA—atopic dermatitis	0.000139	0.000627	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—NGF—atopic dermatitis	0.000138	0.000625	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—CXCL8—atopic dermatitis	0.000138	0.000622	CbGpPWpGaD
Fingolimod—Dizziness—Prednisone—atopic dermatitis	0.000135	0.000398	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—CCR5—atopic dermatitis	0.000134	0.000608	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CXCL10—atopic dermatitis	0.000134	0.000606	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NGF—atopic dermatitis	0.000133	0.000601	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—NGF—atopic dermatitis	0.000133	0.000601	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—CXCL8—atopic dermatitis	0.000132	0.000599	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—CXCL8—atopic dermatitis	0.000132	0.000599	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000132	0.000599	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—IL2—atopic dermatitis	0.000131	0.000594	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CCL5—atopic dermatitis	0.00013	0.00059	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CCR5—atopic dermatitis	0.000129	0.000585	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CCR5—atopic dermatitis	0.000129	0.000585	CbGpPWpGaD
Fingolimod—Headache—Prednisone—atopic dermatitis	0.000128	0.000377	CcSEcCtD
Fingolimod—S1PR5—Signaling by GPCR—IL2—atopic dermatitis	0.000127	0.000572	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—IL2—atopic dermatitis	0.000127	0.000572	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—IL2—atopic dermatitis	0.000127	0.000572	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NGF—atopic dermatitis	0.000121	0.000546	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—CXCL8—atopic dermatitis	0.00012	0.000544	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PPARA—atopic dermatitis	0.000119	0.000539	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CCR5—atopic dermatitis	0.000117	0.000531	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CCL5—atopic dermatitis	0.000115	0.000522	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—IL2—atopic dermatitis	0.000115	0.000519	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—NFKBIA—atopic dermatitis	0.000114	0.000515	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NFKBIA—atopic dermatitis	0.00011	0.000496	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—NFKBIA—atopic dermatitis	0.00011	0.000496	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NGF—atopic dermatitis	0.000107	0.000483	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CCR5—atopic dermatitis	0.000104	0.00047	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NFKBIA—atopic dermatitis	9.96e-05	0.00045	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NFKBIA—atopic dermatitis	8.81e-05	0.000398	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CXCL8—atopic dermatitis	8.13e-05	0.000367	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CXCL8—atopic dermatitis	7.82e-05	0.000354	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CXCL8—atopic dermatitis	7.82e-05	0.000354	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IL2—atopic dermatitis	7.77e-05	0.000351	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—IL6—atopic dermatitis	7.73e-05	0.000349	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IL2—atopic dermatitis	7.48e-05	0.000338	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IL2—atopic dermatitis	7.48e-05	0.000338	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—IL6—atopic dermatitis	7.44e-05	0.000336	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—IL6—atopic dermatitis	7.44e-05	0.000336	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MAPK8—atopic dermatitis	7.15e-05	0.000323	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CXCL8—atopic dermatitis	7.1e-05	0.000321	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MAPK8—atopic dermatitis	6.88e-05	0.000311	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MAPK8—atopic dermatitis	6.88e-05	0.000311	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IL2—atopic dermatitis	6.79e-05	0.000307	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—IL6—atopic dermatitis	6.75e-05	0.000305	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CXCL8—atopic dermatitis	6.29e-05	0.000284	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MAPK8—atopic dermatitis	6.25e-05	0.000282	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GLB1—atopic dermatitis	6.03e-05	0.000273	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IL2—atopic dermatitis	6.01e-05	0.000272	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ADSL—atopic dermatitis	5.78e-05	0.000261	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MAPK8—atopic dermatitis	5.53e-05	0.00025	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IL6—atopic dermatitis	4.56e-05	0.000206	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IL6—atopic dermatitis	4.39e-05	0.000199	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IL6—atopic dermatitis	4.39e-05	0.000199	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GLB1—atopic dermatitis	4.28e-05	0.000193	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ADSL—atopic dermatitis	4.1e-05	0.000185	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IL6—atopic dermatitis	3.99e-05	0.00018	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IL6—atopic dermatitis	3.53e-05	0.00016	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GLB1—atopic dermatitis	2.8e-05	0.000126	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ADSL—atopic dermatitis	2.68e-05	0.000121	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PPARA—atopic dermatitis	1.96e-05	8.85e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PPARA—atopic dermatitis	1.39e-05	6.28e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PPARA—atopic dermatitis	9.08e-06	4.1e-05	CbGpPWpGaD
